Relief Therapeutics Holding AG (RLFTF)

[changes_iv]

Go_wamu, I’m with you on the relationship between the FDA and Big Pharma.

Quote: ...the FDA is in bed with BigPharma? More and more people are suffering from anxiety, depression and other such disorders, such as hopelessness and despair, and the number of people has increased dramatically due to the COVID-19 pandemic. ~go_wamu ——————

While I have your attention, Neuro RX/Relief Therapeutics RLF-100 IV is on Phase III of their modified Phase 2b/3 clinical trials. ————

Phase II >>>
In Phase II, a drug is evaluated for its efficacy and safety in patients with specific diseases. As a rule, these are placebo - controlled trials. Sometimes, Phase II of a clinical trial is divided into phases IIa and IIb. The purposes of Phase II trial are to evaluate short-term safety of a drug (IIa) and to confirm clinical efficacy of a drug and determine the therapeutic dose range (IIb).
——————
Phase III >>>
In Phase III clinical trials, the study drug is given to large groups of patients (thousands of subjects) of different age groups, with different concomitant diseases. These trials are conducted at multiple scientific research sites in different countries. Phase III trials are often randomized controlled studies. These trials investigate all aspects of treatment including assessment of risk / benefit ratio. According to the results of Phase III clinical trials, the decision on registration of the drug product or refusal in its registration is made. Phase III of a clinical trial may be divided into phases IIIa and IIIb as well.
————-
Once Zyesami (TM) IV and inhaler get approved, what studies follow and how fast??? Drug repurposing??? —————-

Drug repurposing is one such strategy. Many agents approved for other uses already have been tested in humans, so detailed information is available on their pharmacology, formulation and potential toxicity. Because repurposing builds upon previous research and development efforts, new candidate therapies could be ready for clinical trials quickly, speeding their review by the Food and Drug Administration and, if approved, their integration into health care. ~ NIH > NCATS.

https://ncats.nih.gov/preclinical/repurpose

Once SPAC merger of Neuro RX and Black Rock is complete, do you see a merger acquisition of Relief Therapeutics by the new Nasdaq-listed Neuro RX??? Would this be supported by large investors like Ives Sagot and GEM???

https://sonix.ai/r/xtrz7PUXeMjvyvbr48n12Ucj/share